This page keeps track of new/upcoming treatment options for eczema. What’s in development? What’s promising? What’s available soon? Find out below… Current topics include anti-IL-33, lebrikizumab, nemolizumab, MOR106, delgocitinib, JAK1 inhibitors, abrocitinib, ASLAN004, skin microbiome, GBR 830, and more.
SubscribeLast updated:
